EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+0.43%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$992M
AUM Growth
+$992M
(+12%)
Cap. Flow
+$36.7M
Cap. Flow
% of AUM
3.7%
Top 10 Holdings %
Top 10 Hldgs %
53.33%
Holding
74
New
18
Increased
22
Reduced
22
Closed
6
Top Buys
| 1 |
Vaxcyte
PCVX
|
$24.1M |
| 2 |
Revvity
RVTY
|
$20.4M |
| 3 |
UnitedHealth
UNH
|
$18.9M |
| 4 |
Illumina
ILMN
|
$18.9M |
| 5 |
Avantor
AVTR
|
$18.9M |
Top Sells
| 1 |
HealthEquity
HQY
|
$20.5M |
| 2 |
HCA Healthcare
HCA
|
$20.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
$18.5M |
| 4 |
Natera
NTRA
|
$16.4M |
| 5 |
Protagonist Therapeutics
PTGX
|
$14.9M |
Sector Composition
| 1 | Healthcare | 99.94% |
| 2 | Financials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dynavax Technologies
DVAX
$1.19B
| $11.9M | 1.09% |
+1,197,189
| New | +$11.9M |
|
27
Mirum Pharmaceuticals
MIRM
$3.75B
| $11.8M | 1.09% |
+232,175
| New | +$11.8M |
|
28
BioCryst Pharmaceuticals
BCRX
$1.74B
| $10.8M | 1% |
1,207,638
-964,798
| -44% | -$8.64M |
|
29
Evolus
EOLS
$477M
| $10.8M | 0.99% |
+1,170,311
| New | +$10.8M |
|
30
Humana
HUM
$37.5B
| $10.7M | 0.98% |
43,620
+15,650
| +56% | +$3.83M |
|
31
Geron
GERN
$893M
| $10.3M | 0.95% |
+7,320,174
| New | +$10.3M |
|
32
Globus Medical
GMED
$7.94B
| $10M | 0.92% |
169,643
-23,250
| -12% | -$1.37M |
|
33
Icon
ICLR
$14B
| $9.39M | 0.86% |
64,587
+53,747
| +496% | +$7.82M |
|
34
NewAmsterdam Pharma
NAMS
$2.8B
| $7.51M | 0.69% |
414,430
+133,479
| +48% | +$2.42M |
|
35
Elevance Health
ELV
$72.4B
| $7.38M | 0.68% |
18,962
+3,264
| +21% | +$1.27M |
|
36
Regeneron Pharmaceuticals
REGN
$59.8B
| $6.96M | 0.64% |
+13,254
| New | +$6.96M |
|
37
Merus
MRUS
$5.04B
| $6.89M | 0.63% |
130,924
+60,595
| +86% | +$3.19M |
|
38
Molina Healthcare
MOH
$9.6B
| $6.14M | 0.56% |
20,600
-3,135
| -13% | -$934K |
|
39
Thermo Fisher Scientific
TMO
$183B
| $5.55M | 0.51% |
+13,685
| New | +$5.55M |
|
40
Edgewise Therapeutics
EWTX
$1.54B
| $5.15M | 0.47% |
+392,739
| New | +$5.15M |
|
41
Danaher
DHR
$143B
| $4.63M | 0.43% |
+23,449
| New | +$4.63M |
|
42
Liquidia Corp
LQDA
$2.52B
| $4.47M | 0.41% |
358,828
+208,348
| +138% | +$2.6M |
|
43
Glaukos
GKOS
$5.42B
| $3.25M | 0.3% |
31,496
-127,461
| -80% | -$13.2M |
|
|
ZBIO
44
Zenas BioPharma, Inc. Common Stock
ZBIO
$722M
| $3.15M | 0.29% |
325,479
-120,109
| -27% | -$1.16M |
|
45
Nektar Therapeutics
NKTR
$543M
| $2.97M | 0.27% |
+115,000
| New | +$2.97M |
|
46
Alector
ALEC
$282M
| $2.78M | 0.26% |
1,986,072
+1,368,654
| +222% | +$1.92M |
|
|
AMRN
47
Amarin Corp
AMRN
$311M
| $2.71M | 0.25% |
167,276
-3,231,928
| -95% | -$43.5K |
|
48
MannKind Corp
MNKD
$1.69B
| $2.61M | 0.24% |
697,710
| – | – |
|
49
89bio
ETNB
$1.37B
| $2.32M | 0.21% |
235,990
-67,741
| -22% | -$665K |
|
50
Repligen
RGEN
$6.54B
| $2.32M | 0.21% |
18,620
+168
| +0.9% | +$20.9K |
|